Compare Puradelta Lestari Tbk. (DMAS) vs Merck Tbk. (MERK) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Puradelta Lestari Tbk. vs Merck Tbk. — how do they compare? Puradelta Lestari Tbk. trades at Rp137 (market cap 6.6T), while Merck Tbk. trades at Rp3,800 (market cap 1.7T). The key difference: Puradelta Lestari Tbk. is far larger — about 3.9× Merck Tbk.'s market cap. Which is the better fit depends on your goals.
| DMAS | MERK | |
|---|---|---|
Market Cap | 6.6T | 1.7T |
Indicative Equilibrium Price | 138 | 3,850 |
Indicative Equilibrium Volume | 1.72K | 1 |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Puradelta Lestari Tbk.
PT Puradelta Lestari Tbk (the Company) was established in Republic of Indonesia based on Notarial Deed of Ano Muhamad Nasruddin No. 77 dated November 12, 1993, a substitute notary of Koswara, S.H., a public notary in Bandung. The Company has changed its status into Foreign Capital Investment (PMA) based on Notarial Deed No. 67 dated October 5, 1996 of Adam Kasdarmadji, S.H., a publicnotary in Jakarta.
Read more on DMAS →About Merck Tbk.
PT Merck Tbk (the Company) is domiciled in Indonesia and located at Jl. TB Simatupang No. 8, Pasar Rebo, East Jakarta, was established in framework of Law No. 1 of 1967 and Law No. 11 of 1970 on foreign capital investment by deed of notary public Eliza Pondaag, SH dated 14 October 1970 No. 29. PT Merck Indonesia is a member of the Merck International Group. The company produces pharmaceutical products with production facility in East Jakarta. It commenced its operation in 1974 in manufacturing medical products, such as Songobian and Neurobion.
Read more on MERK →
